Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Programs
    • HBV
    • Pipeline
  • Patients
    • Commitment
    • Clinical Trials
    • Resources
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health and Safety
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

EASL 2022 – The International Liver Conference

Jun 22 - Jun 26, 2022

Supporting Materials

ABI-H3733 – New Tablet Formulation 396.2 KB
ABI-4334 – Preclinical Characterization 577.2 KB
Vebicorvir – Virologic Suppression and Fibrosis-4 Index 580.1 KB
Vebicorvir – Viral Sequence Diversity During Treatment and Rebound 814 KB
Vebicorvir – Drug-drug Interaction Profile 993.6 KB
Vebicorvir – Disposition and Mass Balance 512.1 KB
Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds
Search Investors

Contact Us

833.509.4583
info@assemblybio.com
LinkedIn
About Programs Patients Collaborations Investors Careers

© 2023 Assembly Biosciences, Inc.